Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

COLAL technology (colonic drug delivery system)

	Next higher product group	oral drug delivery technology_o
	Status	2000-02-01 development existent
	Organisation	Alizyme plc (LSE: AZM)
	Group	Alizyme (Group)

Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for drug delivery technology (drug formulation technology)

[1] Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024"....
[2] ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge....
[3] Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki....
[4] Theragenix Ltd.. (8/31/23). "Press Release: Theragenix and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration". London & Nottingham....
[5] Vitarka Therapeutics Ltd.. (4/6/23). "Press Release: UK Biotech Start-up Secures £1.27M to Revolutionise Intracellular Drug Delivery through Tumour Targeted Technology"....
[6] Ensilicated Technologies Ltd. (EnsiliTech). (1/17/23). "Press Release: Ensilicated Technologies Raises £1.2m to Develop Technology that Eliminates Need for Vaccine Refrigeration". Bristol....
[7] OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford....
[8] Ensilicated Technologies Ltd. (EnsiliTech). (7/27/22). "Press Release: EnsiliTech Spin-out of University of Bath. Ensilicated Technologies Announce Their Spin-out from the University of Bath"....
[9] ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin....
[10] SGS S.A.. (12/7/21). "Press Release: SGS Announces the Acquisition of Quay Pharmaceuticals Limited"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)